ACE-inhibitors and the kidney;ACE-Hemmer und Niere

Wiener Medizinische Wochenschrift

Volumn 146, Issue 11, 1996, Pages 231-235

  Horl W H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

ACE inhibitors; hypertension; renoprotection

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANTIHYPERTENSIVE THERAPY; CAPILLARY PRESSURE; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; DIABETIC NEPHROPATHY; DRUG EFFICACY; GLOMERULONEPHRITIS; GLOMERULUS CAPILLARY; HUMAN; RENOVASCULAR HYPERTENSION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION, RENAL; KIDNEY; KIDNEY FAILURE, CHRONIC; TREATMENT OUTCOME;

EID: 0029960557     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Berkeman J, Rifkin H: Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson): report of a case. Metabolism 1973;22:715-722.
2. Brazy PC, Stead WW, Fitzwilliam JF: Progression of renal insufficiency: role of blood pressure. Kidney Int 1989;35:670-674.
3. De Broe M, Verpooten GA: Pharmacokinetic of ACE inhibitors in hypertensive patients with chronic renal insufficiency. Satellite symposium "ACE inhibition: Prospects for the future", 12th European Congress of Cardiology. Stockholm, 1990 (abstr).
4. Fruncillo RJ, Rocci ML jr, Vlasses PH, Mojaverian P, Sheply K, Clementi RA, Oren A, Smith RD, Till AE, Riley LJ jr, Krishna G, Narins RG, Ferguson RK: Disposition of enalapril and enalaprilat in renal insufficiency. Kidney Int 1987;31 (suppl 20): S117-S122.
5. Gansevoort RT, de Zeeuw D, de Jong PE: Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Kidney Int 1994;45:861-867.
6. Gansevoort RT, de Zeeuw, de Jong PE: Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease. Nephrol Dial Transplant 1995;10:497-504.
7. Gansevoort RT, Sluiter WJ, Hemmelder MH, de Zeeuw D, de Jong PE: Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials. Nephrol Dial Transplant 1995; 10 :1963-1974.
8. Grekas D, Dioudis C, Kalevrosoglou I, Papoulidou F, Goutsaridis N, Alivanis P, Tourkantonis A: Management of moderate to severe hypertension and proteinuria by nifedipine retard and perindopril after renal transplantation. Clin Nephrol 1995;44:299-302.
9. Hannedouche T, Landais P, Goldfarb B, El Esper N, Fournier A, Godin M, Durand D, Chanard J, Mignon F, Suc J-M, Grünfeld J-P: Randomized controlled trial of enalapril and β blockers in non-diabetic chronic renal failure. Br Med J 1994;309:833-837.
10. Heeg JE, de Jong PE, de Zeeuw D: Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-flammatory drug therapy: a clue to the mechnism of action. Clin Sci 1991;81:367-372.
11. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D: Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 1989;36:272-279.
12. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981; 241:F85-F93.
13. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J: Blood pressure and end-stage renal disease in men. N Engl J Med 1996;334:13-18.
14. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992;90:766-771.
15. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-1462.
16. Mann JF, Reisch C, Ritz E: Use of angiotensin-converting enzyme inhibitors for the preservation of kidney function. A retrospective study. Nephron 1990;55 (suppl 1): 38-42.
17. Maschio G, Alberti D, Janin G, Locatelli F, Mann JFE, Motolese M, Ponticelli C, Ritz E, Zuchelli P: Angiotensin-converting-enzyme inhibition in chronic renal insufficiency. N Engl J Med 1996;334:939-945.
18. Parving HH, Andersen AR, Schmidt UM, Hommel E, Mathiesen ER, Svendsen PA: Effective antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 1987;294:1443-1447.
19. Sennesael J, Lamote J, Violet I, Tasse S, Verbeelen D: Comparison of perindopril and amlodipine in cyclosporine-treated renal allograft recipients. Hypertension 1995;26:436-444.
20. Tollins JP, Stone BG, Ran L: Interactions of hypercholesterolemia and hypertension in initiation of glomerula injury. Kidney Int 1992;41:1254-1261.
21. Traindl O, Falger S, Reading S, Banyai M, Liebisch B, Giesinger J, Templ E, Mayer G, Kovarik J: The effects of lisinopril in renal function in proteinuric renal transplant recipients. Transplantation 1993;55:1309-1313.
22. Weidmann P, Böhlen L, de Courten M, et al: Effects of different antihypertensive drugs on human diabetic proteinuria. Nephrol Dial Transplant 1993;8:582-584.
23. Weidmann P, Schneider M, Böhlen L: Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: an up-dated meta-analysis. Nephrol Dial Transplant 1995;10 (suppl 9): 39-43.
24. Wolf G, Mueller E, Stahl RAK, Ziyadeh FN: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-b. J Clin Invest 1993; 92:1366-1372.
25. Wolf G: Vasoactive substances as regulators of renal growth. Exp Nephrol 1993;1:41-51.
26. Zanella MT, Freire M-BS, Milagres R, Ferreira S, Bonomo P-P, Kohlmann O jr, Ribeiro AB: Blood pressure disturbance in diabetes mellitus. J Hypertension 1992; 10 (suppl 7): 59-70.
27. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77:1925-1930.